Latest article
Bayer’s Finerenone Meets Major Endpoint in Section III FIGARO-DKD Cardiovascular Outcomes Research in Sufferers...
WHIPPANY, NJ - (BUSINESS WIRE) - Bayer's phase III cardiovascular outcome study FIGARO-DKD evaluating the efficacy...
Why Extra Folks Are Utilizing Health Apps Than Ever Earlier than
Fitness apps had seen tremendous growth...
Raquel Leviss Is Doing 75 Laborious Problem: Meals, Health Particulars
Raquel Leviss has kicked off a...